| Literature DB >> 28344803 |
Antonio E Pontiroli1, Lara Loreggian2, Marco P L Rovati2, Elena De Patto2, Laura Folini1, Federico Raveglia3, Matilde De Simone4, Alessandro Baisi3, Ugo Cioffi5.
Abstract
BACKGROUND: Low albumin levels and low lymphocyte counts are intra hospital conditions that exert a negative influence on prognosis, healing and length of hospitalization. The study aimed to analyze the correlation between low blood levels of albumin, low lymphocytes, and length of stay. The secondary aim was to identify other co-morbidities associated with prolonged hospital stay.Entities:
Keywords: Albumin; Co-morbidities; Length of stay; Lymphocytes; Screening method
Year: 2017 PMID: 28344803 PMCID: PMC5359975 DOI: 10.1186/s40364-017-0091-x
Source DB: PubMed Journal: Biomark Res ISSN: 2050-7771
Fig. 1Relationship between length of stay (days) and serum albumin levels (g/dl). Legend. White circles indicate patients with emergency admission; black circles indicate patients with routine admission
Fig. 2Relationship between length of stay (days) and lymphocite count (103/ml). 1.0–3.0). Legend. White circles indicate patients with emergency admission; black circles indicate patients with routine admission
Evaluation of lymphocytes and albumin performed within 24–48 h of admission
| Ward | Patients | Albumin evaluated | % Evaluation |
|---|---|---|---|
| Surgery 1st | 411 | 101 | 25% |
| Surgery 2nd | 343 | 160 | 47% |
| Gynecology | 149 | 7 | 5% |
| Obstetrics | 1184 | 35 | 3% |
| Infectious Diseases | 206 | 150 | 73% |
| Medicine 1st | 550 | 432 | 79% |
| Medicine 2nd | 345 | 237 | 69% |
| Medicine 3rd | 291 | 206 | 71% |
| Orthopedics | 278 | 71 | 26% |
| Urology | 281 | 38 | 14% |
| Total | 4038 | 1437 | 36% |
Lymphocytes were evaluated in all patients (100%)
Main patient’s characteristics
| Ward | Total patients | Nr. Male | Nr. Female | Minimum Age | Maximum Age | Mean Age | Median Age |
|---|---|---|---|---|---|---|---|
| Surgery 1st | 411 | 235 | 176 | 18 | 102 | 63.95 ± 19.67 | 66.90 |
| Surgery 2nd | 343 | 198 | 145 | 8 | 102 | 66.58 ± 17.80 | 71.59 |
| Gynecology | 149 | 0 | 149 | 19 | 93 | 49.72 ± 16.58 | 45.72 |
| Obstetrics | 1184 | 0 | 1184 | 15 | 94 | 36.17 ± 6.93 | 36.35 |
| Infectious diseases | 206 | 130 | 76 | 20 | 90 | 55.57 ± 17.04 | 54.25 |
| Medicine 1st | 550 | 262 | 288 | 22 | 105 | 80.29 ± 14.61 | 84.24 |
| Medicine 2nd | 345 | 178 | 167 | 22 | 104 | 79.59 ± 14.92 | 83.10 |
| Medicine 3rd | 291 | 139 | 152 | 21 | 105 | 79.57 ± 15.91 | 83.83 |
| Orthopedics | 278 | 125 | 153 | 8 | 102 | 68.01 ± 21.88 | 73.03 |
| Urology | 281 | 210 | 71 | 22 | 96 | 67.74 ± 16.13 | 70.98 |
| Total | 4038 | 1477 | 2561 | 8 | 105 | 60.27 ± 22.90 | 60.81 |
Frequency of albumin and lymphocytes cases within normal range of laboratory
| Ward | Albumin | Lymphocytes | ||||
|---|---|---|---|---|---|---|
| Total patients | Within normal range | % Normal range | Total patients | Within normal range | % Normal range | |
| Surgery 1st | 101 | 53 | 52% | 411 | 314 | 76% |
| Surgery 2nd | 160 | 78 | 49% | 343 | 230 | 67% |
| Gynecology | 7 | 0 | 0% | 149 | 128 | 86% |
| Obstetrics | 35 | 23 | 66% | 1184 | 1065 | 90% |
| Infectious diseases | 150 | 52 | 35% | 206 | 127 | 62% |
| Medicine 1st | 432 | 125 | 29% | 550 | 336 | 61% |
| Medicine 2nd | 237 | 60 | 25% | 345 | 214 | 62% |
| Medicine 3rd | 206 | 47 | 23% | 291 | 183 | 63% |
| Orthopedics | 71 | 56 | 79% | 278 | 221 | 79% |
| Urology | 38 | 11 | 29% | 281 | 204 | 73% |
| Total | 1437 | 505 | 35% | 4038 | 3022 | 75% |
Correlations between albumin, lymphocytes, co-morbidities, and length of hospital stay
| Hospital days | Albumin | Lymphocytes | N° Comorbidities | |
|---|---|---|---|---|
| Hospital days | 1 | -0.22251 | -0.06075 | 0.31493 |
| <.0001 | 0.0221 | <.0001 | ||
| Albumin | -0.22251 | 1 | 0.07475 | -0.21698 |
| <.0001 | 0.0049 | <.0001 | ||
| Lymphocytes | -0.06075 | 0.07475 | 1 | -0.01401 |
| 0.0221 | 0.0049 | 0.5981 | ||
| N° Comorbidities | 0.31493 | -0.21698 | -0.01401 | 1 |
| <.0001 | <.0001 | 0.5981 |
Number of patients = 1428
Correlation between albumin and lymphocytes and length of hospital stay, by ward
| Ward | Albumin | Lymphocytes | ||||
|---|---|---|---|---|---|---|
| Patients | r | Patients | r | |||
| Surgery 1st | 101 | -0.40901 | <0.0001 | 378 | -0.13963 | 0.0065 |
| Surgery 2nd | 160 | -0.21696 | 0.0059 | 326 | -0.03280 | 0.5551 |
| Gynecology | 0.08426 | 0.8575 | 111 | -0.11816 | 0.2168 | |
| Obstetrics | -0.02260 | 0.8975 | 743 | -0.03041 | 0.4078 | |
| Infectious diseases | 150 | -0.30501 | 0.0001 | 203 | -0.13200 | 0.0605 |
| Medicine 1st | 432 | -0.23764 | <0.0001 | 543 | -0.07096 | 0.0986 |
| Medicine 2nd | 237 | -0.22700 | 0.0004 | 341 | -0.09080 | 0.0941 |
| Medicine 3rd | 206 | -0.17835 | 0.0103 | 285 | -0.09362 | 0.1148 |
| Orthopedics | 71 | -0.24059 | 0.0433 | 229 | -0.17315 | 0.0086 |
| Urology | -0.39124 | 0.0151 | 216 | -0. 04059 | 0.5530 |
Small samples are indicated in red bold
Correlation between albumin and lymphocytes and length of hospital stay, by diagnosis
| Diagnosis | Albumin | Lymphocytes | ||||
|---|---|---|---|---|---|---|
| Patients | r | Patients | r | |||
| Malignant tumors | 206 | -0.16027 | 0.0214 | 343 | -0.00565 | 0.9170 |
| Benign tumors | -0.22459 | 0.5067 | 85 | -0.15118 | 0.1672 | |
| Inflammatory diseases | 95 | -0.17584 | 0.0883 | 206 | -0.12299 | 0.0782 |
| Infections | 397 | -0.23001 | <0.0001 | 649 | -0.12547 | 0.0014 |
| Hemorrhagic conditions | 60 | -0.35899 | 0.0049 | 131 | -0.05823 | 0.5089 |
| Fractures | 71 | -0.31096 | 0.0083 | 202 | -0.14823 | 0.0353 |
| Pregnancy/Childbirth | -0.52093 | 0.0064 | 613 | -0.08906 | 0.0275 | |
| Others | 567 | -0.23845 | <0.0001 | 1146 | -0.04780 | 0.1058 |
Small samples are indicated in red bold
Fig. 3Percentage of patients with a given length of stay (in days). Legend. The line describes the fitted Normal distribution
Fig. 4Normal Quantile-Quantile Plot for length of stay. Legend. The plot compares the ordered values of length of stay (days) with quantiles of the normal distribution. If the data distribution matches the theoretical distribution, the points on the plot form a linear pattern
Regression analysis – estimates of maximum likelihood
| Parameter | Level_1 | Estimate | Standard Error | Lim. Conf. < 95% | Lim. Conf. > 95% | Pr > | |
|---|---|---|---|---|---|---|---|
| Albumin | -0.1479 | 0.0473 | -0.2405 | -0.0553 | 9.79 | 0.0018 | |
| Lymphocytes | 0.0717 | 0.0415 | -0.0097 | 0.1530 | 2.98 | 0.0843 | |
| Number of Comorbidities | 0.2625 | 0.0255 | 0.2125 | 0.3126 | 105.76 | <0.0001 | |
| Red Blood Cells | 0.1008 | 0.0428 | 0.0170 | 0.1846 | 5.56 | 0.0184 | |
| Platelets | 0.0008 | 0.0003 | 0.0001 | 0.0014 | 5.88 | 0.0154 | |
| Diagnosis 1 | Infections | -0.0334 | 0.1631 | -0.3531 | 0.2863 | 0.04 | 0.8376 |
| Diagnosis 2 | Malignant tumors | 0.0600 | 0.1208 | -0.1768 | 0.2967 | 0.25 | 0.6195 |
| Diagnosis 3 | Benign tumors | 0.4561 | 0.2490 | -0.0320 | 0.9441 | 3.35 | 0.0670 |
| Diagnosis 4 | Other | -0.0107 | 0.1310 | -0.2675 | 0.2461 | 0.01 | 0.9347 |
| Diagnosis 5 | Fracture | 0.2357 | 0.1305 | -0.0200 | 0.4913 | 3.26 | 0.0708 |
| Diagnosis 6 | Pregnancy and childbirth | -0.5629 | 0.2357 | -1.0249 | -0.1009 | 5.70 | 0.0169 |
| Diagnosis 7 | Haemorrhagic conditions | -0.0037 | 0.1764 | -0.3494 | 0.3420 | 0.00 | 0.9834 |
| Diagnosis 8 | Inflammatory diseases | 0 | 0 | 0 | 0 | . | . |
Likelihood ratio – significance analysis
| Origin | Pr > | Index | Hospital days | |
|---|---|---|---|---|
| Platelets | 29.14 | <0.0001 | ↑ | ↑ |
| Age | 52.23 | <0.0001 | ↑ | ↑ |
| Number of Co-morbidities | 289.12 | <0.0001 | ↑ | ↑ |
| Diagnosis | 125.36 | <0.0001 | Inflammatory diseases excluded | |
| Gender | 8.33 | 0.0039 | Male | ↑ |
| Recovery | 21.15 | <0.0001 | Urgent | ↑ |
Stepwise selection for patients with albumin value
| Summary of stepwise selection | ||||||||
|---|---|---|---|---|---|---|---|---|
| Step | Input | R2 (partial) | F Value | Pr > F | Lambda Wilks | Pr < Lambda | Average Squared Canonical Correlation | Pr > ASCC |
| 1 | Age at recovery | 0,1664 | 658,77 | <,0001 | 0,8336 | <,0001 | 0,1664 | <,0001 |
| 2 | Days of recovery | 0,0454 | 156,69 | <,0001 | 0,7957 | <,0001 | 0,2043 | <,0001 |
| 3 | White blood count (WBC) 10^3/ul 4.0 – 10.0 | 0,0049 | 16,31 | <,0001 | 0,7918 | <,0001 | 0,2082 | <,0001 |
| 4 | Monocytes (absolute nr) 10^3/ul 0.2 – 1.0 | 0,0024 | 8,03 | 0,005 | 0,7899 | <,0001 | 0,2101 | <,0001 |
| 5 | Mean corpuscular hemoglobin concentration (MCHC) g/dl 31.5 – 34.5 | 0,0021 | 6,84 | 0,009 | 0,7883 | <,0001 | 0,2117 | <,0001 |
| 6 | Platelets (PLT) 10^3/uL 150 – 450 | 0,0017 | 5,58 | 0,018 | 0,7869 | <,0001 | 0,2131 | <,0001 |
| 7 | Eosinophils (absolute nr) 10^3/ul 0.0 – 0.5 | 0,0012 | 3,81 | 0,051 | 0,7860 | <,0001 | 0,2140 | <,0001 |